Polyprenols mitigate cognitive dysfunction and neuropathology in the APP/PS1 mouse

Phytotherapy Research : PTR
Xu-Xu ZhuangLing He

Abstract

Alzheimer's disease (AD) is a very common neurodegenerative disorder in the elderly and brings considerable financial and social problems worldwide. In this study, polyprenols were firstly evaluated the effects on the cognitive deficits and neuropathology in APP/PS1 mice model of AD. At 3 months old, the APP/PS1 mice were divided into model group; polyprenols low, middle, and high dosage group; and positive drug group. Age-matched wild-type mice were chosen in control group. The administration by oral gavage lasted 6 months. Polyprenols treatment significantly improved cognitive impairment of double transgenic mice compared with vehicle control treatment in behavioral tests. In addition, immunohistochemistry and enzyme-linked immunosorbent assay showed that there were significantly reductions in neuritic plaques and the level of hyperphosphorylated tau in brain of polyprenols-treated mice. Furthermore, we found that polyprenols treatment reduced the apoptotic cells in brain sections of 9-month-old APP/PS1 mice. These results reveal that polyprenols exert neuroprotective effects in APP/PS1 mice and could represent an effective treatment for AD.

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
Jul 15, 1996·Archives of Biochemistry and Biophysics·P Påhlsson, S L Spitalnik
Oct 1, 1996·The Journal of Clinical Investigation·F M LaFerlaG Jay
Oct 26, 2000·Nature·J Yuan, B A Yankner
May 5, 2001·Biomolecular Engineering·J L JankowskyD R Borchelt
Jun 5, 2004·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·M S Parihar, Taruna Hemnani
Mar 16, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hidenori EndoPak H Chan
Oct 17, 2007·Neurology·Jeffrey L CummingsChristopher Clark
Jun 10, 2008·Expert Opinion on Emerging Drugs·Walter J Lukiw
Aug 15, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Suzanne E HickmanJoseph El Khoury
Oct 28, 2008·Brain : a Journal of Neurology·D BocheJ A R Nicoll
Oct 2, 2009·Nature Reviews. Drug Discovery·Kurt R BrundenVirginia M-Y Lee
Jun 7, 2011·Drugs & Aging·Melanie-Jayne R Howes, Elaine Perry
Feb 7, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Julia FedotovaNatalia Ordayn
Mar 20, 2012·Cell·Yadong Huang, Lennart Mucke
Jun 20, 2012·Journal of Alzheimer's Disease : JAD·Jian-Zhi WangKhalid Iqbal
Sep 11, 2012·Nature·Ewen Callaway

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.